Psycho-pharmotherapy of battle post-traumatic stress disorder (Review of clinical searches)
- Authors: Reshetnikov V.A1, Reznik A.M1
-
Affiliations:
- Issue: Vol 330, No 3 (2009)
- Pages: 42-47
- Section: Articles
- URL: https://journals.eco-vector.com/0026-9050/article/view/74879
- DOI: https://doi.org/10.17816/RMMJ74879
- ID: 74879
Cite item
Abstract
Full Text
References
- Волошин В. М. Посттравматическое стрессовое расстройство (феноменология, клиника, систематика, динамика и современные подходы к психофармакотерапии). - М.: Анахарсис, 2005. - 200 с.
- Линдауэр Р.Й.Л., Карльер И.В.Е., Герсонс Б.П.Р. Нейробиология посттравматического стрессового расстройства // Социал. и клинич. психиатрия. - 2003. - Т. 13, вып.1. - С. 146-150.
- Литвинцев С.В, Снедков Е.В., Резник А.М. Боевая психическая травма: Руководство для врачей. - М.: Медицина, 2005. - 432 с.
- Решетников В.А., Курышов В.Н., Дворник А.В., Бриль А.Г. Синдром посттравматического стрессового расстройства: Учебнометодические рекомендации. - Саратов: СГМУ, 2001. - 15 с.
- Фоа Э., Кин Т.М., Фридман М. и др. Эффективная терапия посттравматического стрессового расстройства. - М.: Когито-Центр, 2005. - 467 с.
- Ahearn E.P., Krohn A., Connor K.M., Davidson J.R. Pharmacologic treatment of posttraumatic stress disorder: a focus on antipsychotic use // Ann. Clin. Psyshiatry. - 2003. - Sep.-Dec. 15 (3-4). - P. 193-201.
- Battista M.A., Hierholzer R., Khouzam H.R. et al. Pilot trial of memantine in the treatment of posttraumatic stress disorder // Psychiatry. - 2007. - 70 (2). - 167-174.
- Brady K.T., Clary C.M. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline // Compr. Psychiatry. - 2003. - Vol. 44, N 5. - P. 360-369.
- Bremner J.D. The relationship between cognitive and brain changes in posttraumatic stress disorder // Ann. N.Y. Acad. Sci. - 2006. - Jul., 1071. - P. 80-86.
- Davidson J.R. Treatment of posttraumatic stress disorder: the impact of paroxetine // Psychopharmacol. Bull. - 2003. - Vol. 37. - P. 76-88.
- Davis L.L., Davidson J.R., Ward L.C. et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebocontrolled trial in a veteran population // J. Clin. Psychopharmacol. - 2008. - 28 (1). - P. 84-88.
- Davis L.L., English B.A., Ambrose S.M., Petty F. Pharmacotherapy for post-traumatic stress disorder: a comprehensive review // Expert. Opin. Pharmacother. - 2001. - Oct. 2 (10). - P. 1583- 1595.
- Escalona R., Canive J.M., Calais L.A., Davidson J.R. Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder // Depress. Anxiety. - 2002. - 15 (1). - P. 29-33.
- Hamner M.B., Deitsch S.E., Brodrick P.S. et al. Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy // J. Clin. Psychopharmacology. - 2003. - Feb. 23 (1). - P. 15-20.
- Jakovljevic M., Sagud M., Mihaljevic-Peles A. Olanzapine in the treatment-resistant, combat-related PTSD - a series of case reports // Acta Psychiatrica Scand. - 2003. - 107 (5). - P. 394-396.
- Jones F.D. Chronic post-traumatic stress disorders // Textbook of Military Medicine. Part 1. War Psychiatry. - 1995. - P. 409-430.
- Lawford B.R., Young R., Noble E.P., Kann B., Ritchie T. The D2 dopamine receptor (DRD2) gene is associated with co-morbid depression, anxiety and social dysfunction in untreated veterans with post-traumatic stress disorder // Eur. Psychiatry. - 2006. - Vol. 21 (3). - P. 180-185.
- Lindley S.E., Carlson E.B., Hill K. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic posttraumatic stress disorder // J. Clin. Pharmacology. - 2007. - Dec. 27 (6). - P. 677- 681.
- Marmar C.R., Cshoenfeld F., Weiss D.S. et al. Open trial of Fluvoxamine treatment for combat-related posttraumatic stress disorder // Clin. Psychiatry. - 1996. - Suppl. 8. - P. 66-70.
- Mellman T.A., Clark R.E., Peacock W.J. Prescribing patterns for patients with posttraumatic stress disorder // Psychiatr. Serv. - 2003. - Vol. 54, N 12. - P. 1618-1621.
- Monnelly E.P., Ciraulo D.A., Knapp C., Keane T. Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder // J. Clin. Psychopharmacology. - 2003. - Vol. 23 (2). - P. 193-196.
- Neylan T.C., Lenoci M., Maglione M.L. et al. The effect of nefazodone on subjective and objective sleep quality in posttraumatic stress disorder // J. Clin. Psychiatry. - 2003. - Apr. 64 (4). - P. 445-450.
- Neylan T.C., Metzler T.J., Schoenfeld F.B. et al. Fluvoxamine and sleep disturbances in posttraumatic stress disorder // Trauma Stress. - 2001. - Jul. 14 (3). - P. 461-467.
- Petty F., Brannan S., Casada J et al. Olanzapine treatment for post-traumatic stress disorder: an open-label study // Int. Clin. Psychopharmacology. - 2001. - Nov. 16 (6). - P. 331-337.
- Pivac N., Kozaric-Kovacic D., Muck-Seler D. Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder //Psycho-pharmacology (Berl.). - 2004. - Oct. 175 (4). - P. 451-456.
- Seedat S., Stein D.J., Emsley R.A. Open trial of citalopram in adults with post-traumatic stress disorder // Int. J. Neuropsychopharmacology. - 2000. - Jun. 3 (2). - P. 135-140.
- Sokolski K.N., Denson T.F., Lee R.T., Reist C. Quetiapine for treatment of refractory symptoms of combat-related post-traumatic stress disorder // Mil. Med. - 2003. - Vol. 168, N 6. - P. 486-489.
- Stein M.B., Kline N.A., Matloff J.L. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study // Am. J. Psychiatry. - 2002. - Vol. 159 (10). - P. 1777-1779.
- Viola J., Ditzler T., Batzer W. et al. Pharmacological management of post-traumatic stress disorder: clinical summary of a five-year retrospective study, 1990-1995 // Mil. Med. - 1997. - Vol. 162, N 9. - P. 616-619.